Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard trea...
Saved in:
| Main Author: | Santamato A |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-01-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/safety-and-efficacy-of-incobotulinumtoxina-as-a-potential-treatment-fo-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-Dose <i>IncobotulinumtoxinA</i> in the Treatment of Early-Stage Knee Osteoarthritis: Results from a Preliminary Single-Arm Clinical Trial
by: Sofia Durán-Hernández, et al.
Published: (2025-04-01) -
Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
by: Richard D. Zorowitz, et al.
Published: (2025-02-01) -
Delphi Consensus on the Management of Spanish Patients with Post-Stroke Hemiplegic Shoulder Pain Treated with Botulinum Toxin A: Result Study
by: Carlos Cordero-García, et al.
Published: (2025-01-01) -
Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea
by: A. L. Kurenkov, et al.
Published: (2022-04-01) -
Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
by: Mohammad Sajjad Rahnama'i, et al.
Published: (2024-01-01)